APN 2021 - November 9-10
Dear Colleagues,
It is my great pleasure to announce the 2022 Asian Pharmacometrics Network
(APN) symposium to be held virtually on November 9-10.
Following previous years, speakers this year were also invited from various
Asian countries (11 Asian countries), keeping making it the unique Asian
meeting fully representing the diversity of the region.
Registration is free and its procedure and the program are found at
https://pagmas.github.io/apn-2022/
Satellite workshops are scheduled prior to the symposium, the detail of which
will be provided soon.
For more information, contact the local host Dr. Lo Yoke Lin of International
Medical University, Malaysia at [email protected]<mailto:[email protected]>
or APN Symposium Secretariat at
[email protected]<mailto:[email protected]>
With 16 member countries currently, APN has kept organizing its meeting to be
as diverse as possible since its inaugural meeting in 2019, which is to fulfill
the APN’s goal of enhancing and expanding regional development and networking
opportunities in pharmacometrics in the Asian region.
For more information, you may want to look at the following paper recently
published in CPT: PSP.
The Asian Pharmacometrics Network: The historical background, establishment,
objectives and roles, and recent activities. CPT: Pharmacometrics & Systems
Pharmacology. 11(4):403-408 (Apr 2022)
Best regards,
APN Chair
Kyungsoo Park
---------------------------------------
Kyungsoo Park, PhD, MD
Professor of Pharmacology
Yonsei University College of Medicine
50-1 Yonsei-Ro, Seoul 03722, Korea
Tel +82-2-2228-1735 / Fax +82-2-313-1894
상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는
영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는
사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above
message is intended solely for the named addressee and may contain trade
secret, industrial technology or privileged and confidential information
otherwise protected under applicable law including the Unfair Competition
Prevention and Trade Secret protection act. Any unauthorized dissemination,
distribution, copying or use of the information contained in this communication
is strictly prohibited. If you have received this communication in error,
please notify the sender by email and delete this communication immediately.